NDC 50090-6089-01 - Levothyroxine sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-6089
- Requested NDC
- 50090-6089-01
- Package NDCs from labels
- 50090-6089-0, 50090-6089-1, 50090-6089-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2025-07-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levothyroxine sodium - A-S Medication Solutions | A-S Medication Solutions | 2025-07-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6089-0 | Levothyroxine sodium | 90 in 1 BOTTLE | TABLET | 90 | 5 | |
| 50090-6089-1 | Levothyroxine sodium | 30 in 1 BOTTLE | TABLET | 30 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6089 | LEVOTHYROXINE SODIUM TABLET [A-S MEDICATION SOLUTIONS] | 3 | Current NDC, Legacy NDC, 2 package rows | 20230602_70d84fe0-afc4-4ef2-b4d8-f156abac3d1f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6089-0 | EA - Each | 50090-6089 | 1b7b2683-840d-46d0-917e-a7d77279de70 | 1 | 2022-10-06 |
| 50090-6089-1 | EA - Each | 50090-6089 | bbb03dd6-2ec1-454d-b7e9-edf6bd5c9c2f | 1 | 2022-10-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 59762069-5ea7-43d9-ba5b-8b250767b146 | 2023-09-14 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| Anubis Barcelona | GLYCERIN, SORBITOL, ALOE BARBADENSIS LEAF JUICE | ANUBIS COSMETICS SL | eb651769-4d98-2b3b-e053-2a95a90a36b0 | 2023-09-01 | Warnings | H3R47K3TBD |
| Anubis Barcelona Total Hydrating | BETAINE, GLYCERIN, POLYSORBATE 20 | ANUBIS COSMETICS SL | eaefe3b9-9064-18b1-e053-2a95a90a5765 | 2023-09-01 | Warnings | H3R47K3TBD |
| Anubis Barcelona New Even | LACTIC ACID, CITRIC ACID, GLYCOLIC ACID | ANUBIS COSMETICS SL | eaeeb6e0-5322-20c4-e053-2995a90a9fd9 | 2023-09-01 | Warnings | H3R47K3TBD |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 51a27110-e787-409b-98ba-c6471d0ad5cf | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 966248 892251 966222 966270 892246 966221 892255 966224 966249 966220 966225 966253 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | Camber Pharmaceuticals, Inc. | b1ba1c7d-371a-4aa8-bee8-dd29b5e7da7e | 2023-01-23 | Boxed warning, Warnings, Adverse reactions | 966248 892251 966222 966270 892246 966221 892255 966224 966249 966220 966225 966253 9J765S329G |
| Vitrexyl plus Iron | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | ada43056-a3ce-e7de-e053-2a95a90aa046 | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Vitrexyl | FOLIC ACID | PureTek Corporation | ae064a9e-daba-fa86-e053-2a95a90a16a7 | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Vitranol Fe | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | b81daf17-430b-6ba2-e053-2a95a90a768b | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Vitrexate | FOLIC ACID | PureTek Corporation | b34fee43-bea9-45b7-e053-2a95a90aad4d | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Vitrexate FE | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | b3637def-a701-673a-e053-2995a90a02d5 | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Venexa | FOLIC ACID | PureTek Corporation | ba130779-cdfd-086d-e053-2a95a90a2590 | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Venexa FE | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | ba142128-21c4-4204-e053-2a95a90ae0d7 | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Ribotin-E | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb1492c5-bfcd-d632-e053-2a95a90ad7d1 | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Ventrixyl Fe | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | c7a626ec-88ec-d899-e053-2a95a90ab0ba | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Zintrexyl-C | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb1492c5-bfca-d632-e053-2a95a90ad7d1 | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 2f129a3d-f3e6-45b2-9704-3ad171cbd8a5 | 2022-08-01 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966224 9J765S329G |
| Magnesia Oxydata | MAGNESIA OXYDATA | Hahnemann Laboratories, INC. | e45bc2b0-72f4-42e1-e053-2995a90a0e66 | 2022-07-21 | 3A3U0GI71G | |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 329b6eb2-4fa3-41f6-a6ff-96d94b7a65bf | 2022-07-01 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966221 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 9d1aaa2d-c8c0-478f-8540-f92f6512cfcb | 2022-05-01 | Boxed warning, Warnings, Adverse reactions | ANDA212399 892246 9J765S329G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.